Kitt MM - Search Results

1

Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy.

Gibson CM, Murphy SA, Marble SJ, Cohen DJ, Cohen EA, Lui HK, Young J Jr, Kitt MM, Lorenz TJ, Tcheng JE. Gibson CM, et al. Among authors: kitt mm. Am Heart J. 2002 Jan;143(1):106-10. doi: 10.1067/mhj.2002.119618. Am Heart J. 2002. PMID: 11773919 Clinical Trial.

2

Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy.

Gibson CM, Cohen DJ, Cohen EA, Lui HK, Murphy SA, Marble SJ, Kitt M, Lorenz T, Tcheng JE. Gibson CM, et al. Am J Cardiol. 2001 Jun 1;87(11):1293-5. doi: 10.1016/s0002-9149(01)01524-7. Am J Cardiol. 2001. PMID: 11377359 Clinical Trial. No abstract available.

3

Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention.

O'shea JC, Madan M, Cantor WJ, Pacchiana CM, Greenberg S, Joseph DM, Kitt MM, Lorenz TJ, Tcheng JE. O'shea JC, et al. Among authors: kitt mm. Am Heart J. 2000 Dec;140(6):834-9. doi: 10.1067/mhj.2000.110458. Am Heart J. 2000. PMID: 11099985

4

Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention.

O'Shea JC, Buller CE, Cantor WJ, Chandler AB, Cohen EA, Cohen DJ, Gilchrist IC, Kleiman NS, Labinaz M, Madan M, Hafley GE, Califf RM, Kitt MM, Strony J, Tcheng JE; ESPRIT Investigators. O'Shea JC, et al. Among authors: kitt mm. JAMA. 2002 Feb 6;287(5):618-21. doi: 10.1001/jama.287.5.618. JAMA. 2002. PMID: 11829701 Clinical Trial.

5

Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial).

Reddan DN, O'Shea JC, Sarembock IJ, Williams KA, Pieper KS, Santoian E, Owen WF, Kitt MM, Tcheng JE. Reddan DN, et al. Among authors: kitt mm. Am J Cardiol. 2003 Jan 1;91(1):17-21. doi: 10.1016/s0002-9149(02)02991-0. Am J Cardiol. 2003. PMID: 12505565 Clinical Trial.

6

Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention.

Tcheng JE, Madan M, O'Shea JC, Cohen EA, Buller CE, Lincoff AM, Popma JJ, Teirstein PS, Kitt MM, Lorenz TJ, Greenberg S, Fost N, Califf RM. Tcheng JE, et al. Among authors: kitt mm. J Interv Cardiol. 2003 Apr;16(2):97-105. doi: 10.1046/j.1540-8183.2003.08020.x. J Interv Cardiol. 2003. PMID: 12768912

7

Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy).

Rebeiz AG, Dery JP, Tsiatis AA, O'shea JC, Johnson BA, Hellkamp AS, Pieper KS, Gilchrist IC, Slater J, Muhlestein JB, Joseph D, Kitt MM, Tcheng JE; ESPRIT substudy. Rebeiz AG, et al. Among authors: kitt mm. Am J Cardiol. 2004 Oct 1;94(7):926-9. doi: 10.1016/j.amjcard.2004.06.030. Am J Cardiol. 2004. PMID: 15464679 Clinical Trial.

8

Bailout use of platelet glycoprotein IIb-IIIa inhibition during coronary stent implantation: observations from the ESPRIT trial.

Cantor WJ, Madan M, O'Shea JC, Chisholm RJ, Lui HK, Cohen DJ, Feldman RL, Green R, Hellkamp AS, Kitt MM, Tcheng JE. Cantor WJ, et al. Among authors: kitt mm. J Invasive Cardiol. 2005 Jul;17(7):360-4. J Invasive Cardiol. 2005. PMID: 16003020 Clinical Trial.

9

The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study.

Cohen AT, Harrington R, Goldhaber SZ, Hull R, Gibson CM, Hernandez AF, Kitt MM, Lorenz TJ. Cohen AT, et al. Among authors: kitt mm. Am Heart J. 2014 Mar;167(3):335-41. doi: 10.1016/j.ahj.2013.11.006. Epub 2013 Dec 10. Am Heart J. 2014. PMID: 24576517 Free article. Clinical Trial.

10

Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial.

O'Shea JC, Hafley GE, Greenberg S, Hasselblad V, Lorenz TJ, Kitt MM, Strony J, Tcheng JE; ESPRIT Investigators (Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy trial). O'Shea JC, et al. Among authors: kitt mm. JAMA. 2001 May 16;285(19):2468-73. doi: 10.1001/jama.285.19.2468. JAMA. 2001. PMID: 11368699 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters